← Leaderboards
Ahmed Nabil Zobi
Syntr Health Technologies, Llc
$2,404,336
Attributed
$2,554,336
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,554,336 · 5
By mechanism
R43$1,504,060 · 4
R44$1,050,276 · 1
Top collaborators
- Alan D Widgerow1 shared
Most similar at Syntr Health Technologies, Llc
Same institution · by research overlap
- Alan D Widgerow$150,000
Others in their field
Other Emerging Leaders on “Health Technology”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$367,305,486
- Joel A Lipkin · Four Points Technology, Llc$182,936,915
- Lynn Briscoe · Leidos Biomedical Research, Inc.$121,039,500
- Terry Drinkwine · Carahsoft Technology Corporation$93,011,563
Research focus
Health TechnologyTissuesGrantCellsDevicesAnimal ModelDissociationDiabetic Foot UlcerTechnology PlatformBackHeterogeneityWound ClosureSmall Business Innovation Research GrantAutologousAdipose TissueHealingMicrofluidicsDesignTechnologyTumor TissueAdoptionDiabetic UlcerAging PopulationInvestigation
Grant awards (6)
Device Automation of an FDA-cleared CD-Microfluidic Platform for Rapid Tissue Microsizing$1,050,276
R44 · FY2025 · TR · contact PI
Rapid and Automated Dissociation of Tumor Tissue for Single Cell Diagnostics$406,500
R43 · FY2025 · TR · contact PI
Accelerating Bioengineering Approaches for Increasing Access to New Solutions Targeting Breast Cancer Reconstructive Surgery$356,500
R43 · FY2025 · CA · contact PI
Device Automation of an FDA-cleared CD-Microfluidic Platform for Rapid Tissue Microsizing$306,161
R43 · FY2024 · TR · contact PI
Device Automation of an FDA-cleared CD-Microfluidic Platform for Rapid Tissue Microsizing$134,899
R43 · FY2024 · TR · contact PI
Mechanical Activation of Adipose-Derived Stem Cells for the Treatment of Diabetic Foot Ulcers Using a Novel CD-Microfluidic Device$300,000
R43 · FY2017 · DK · contact PI